Deep Genomics, a leading artificial intelligence (AI) therapeutics company based in Toronto, has attractedapproximately US $224M in funding for its AI workbench that can decode biology to program life-changing medicines.
Researchers require technology to store, transfer, and process biological data accurately and quickly to make drug discovery more efficient. Deep Genomics, a leading artificial intelligence (AI) therapeutics company based in Toronto, has attractedapproximately US $224M in funding for its AI workbench that can decode biology to program life-changing medicines.